[1] PubMed ID: | 35730141 |
Disease Name: | Aortic Aneurysm, Thoracic |
Sample: | VSMCs, TAA tissues |
Dysfunction Pattern: | Interaction(IGF2BP3/KIAA1522) |
Validated Method: | RNA Pull-Down//Western Blot//Transfection//Tunel//CCK8//qRT-PCR//FISH//RIP//Luciferase Report Assay//Cell Apoptosis Assay//EdU Staining |
Description: | HOXA-AS2 was detected to have significantly high expression in TAA tissues and function as an oncogene to promote proliferation of VSMCs, while inhibiting cell apoptosis (Figure 1, **P < 0.01). HOXA-AS2 was unveiled to bind with miR-520d-3p (Figure 2, *P < 0.05, **P < 0.01) and further up-regulate KIAA1522 to facilitate the growth of VSMCs (Figure 3-4, *P < 0.05, **P < 0.01). HOXA-AS2 was also found to recruit IGF2BP3 to stabilize KIAA1522 mRNA (Figure 5, **P < 0.01). |
Causality: | Yes |
Causal Description: | HOXA-AS2 was detected to have significantly high expression in TAA tissues and function as an oncogene to promote proliferation of VSMCs, while inhibiting cell apoptosis (Figure 1, **P < 0.01). |
Clinical-realted Application: | |
|